Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8613 |
High Similarity |
NPD2935 |
Discontinued |
0.8462 |
Intermediate Similarity |
NPD9717 |
Approved |
0.8358 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.8357 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8346 |
Intermediate Similarity |
NPD9493 |
Approved |
0.8235 |
Intermediate Similarity |
NPD411 |
Approved |
0.8188 |
Intermediate Similarity |
NPD447 |
Suspended |
0.8188 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8163 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.8156 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8138 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8138 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8138 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8134 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8112 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD4626 |
Approved |
0.8074 |
Intermediate Similarity |
NPD2798 |
Approved |
0.8058 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7941 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7842 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7842 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7832 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.78 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7794 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7778 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7778 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7778 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7762 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7762 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7761 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.774 |
Intermediate Similarity |
NPD3750 |
Approved |
0.774 |
Intermediate Similarity |
NPD7003 |
Approved |
0.774 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.773 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7727 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7718 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7717 |
Intermediate Similarity |
NPD74 |
Approved |
0.7717 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7712 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7704 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7676 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7673 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7662 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7655 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7655 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7652 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7622 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7619 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7603 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7597 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7586 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7586 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7586 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7586 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7584 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7582 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7574 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7574 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7556 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7554 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7552 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7551 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7534 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7534 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7534 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7533 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7532 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7518 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7517 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7483 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7482 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7482 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7482 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7482 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7469 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7466 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7466 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7466 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7465 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7462 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.746 |
Intermediate Similarity |
NPD9261 |
Approved |
0.7455 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7455 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7451 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7415 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7415 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD2344 |
Approved |
0.741 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7407 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7375 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7375 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7357 |
Intermediate Similarity |
NPD6362 |
Approved |
0.7353 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7343 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7342 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7317 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD37 |
Approved |
0.7308 |
Intermediate Similarity |
NPD2182 |
Approved |
0.7305 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD17 |
Approved |
0.7286 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7284 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7278 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7266 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7261 |
Intermediate Similarity |
NPD2801 |
Approved |
0.726 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7256 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7254 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7246 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1511 |
Approved |
0.723 |
Intermediate Similarity |
NPD6100 |
Approved |
0.723 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7229 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD2649 |
Approved |
0.7226 |
Intermediate Similarity |
NPD2651 |
Approved |
0.7226 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7214 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7195 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.719 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD4662 |
Approved |
0.719 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7185 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7172 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7172 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7172 |
Intermediate Similarity |
NPD520 |
Approved |
0.7172 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD4966 |
Approved |
0.717 |
Intermediate Similarity |
NPD4965 |
Approved |
0.717 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7164 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7154 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7153 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7135 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD2897 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7132 |
Intermediate Similarity |
NPD164 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD2203 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7107 |
Intermediate Similarity |
NPD2379 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD290 |
Approved |
0.7099 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7097 |
Intermediate Similarity |
NPD920 |
Approved |
0.7091 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7086 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD1578 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7071 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7071 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7067 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7066
|
Intermediate Similarity |
NPD6797 |
Phase 2 |